MR scan study for liver cancer and healthy volunteers
Part of Cancer, Digestive system clinical trials.
This study uses a special MRI machine to take detailed images of the liver. It includes people newly diagnosed with liver cancer who haven't had treatment yet, as well as healthy volunteers for comparison. The goal is to see how well the machine works for different patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are able to follow instructions and cooperate during the scan.
- You are willing to sign a consent form to participate.
- If you have liver cancer: you have been diagnosed with primary liver cancer and have not yet received any cancer treatment.
- If you are a healthy volunteer: you have no history of liver disease.
- You do not have any metal implants (like a pacemaker or insulin pump) or other items that are not safe for MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
This trial studies a faster MRI scan to help track early liver cancer in people who have cirrhosis and are considered high risk. It may improve how often and how well doctors can look for changes without using longer imaging sessions.
This study looks at ways to improve screening for liver cancer in adults with long-term liver disease. It may help catch liver cancer earlier, which can make treatment easier.
This trial compares a shorter MRI using a special dye to a CT scan for detecting liver cancer recurrence in people who have been cancer-free for at least two years after surgery or local treatment.
This trial compares two types of imaging scans (CEUS and AMRI) to see which one is better at finding liver cancer (HCC) in patients who have an unclear spot on their liver (an indeterminate nodule). It is for people with cirrhosis who have at least one such nodule but no confirmed liver cancer yet.
This study compares a shorter, non-contrast MRI and ultrasound to monitor for liver cancer in people with cirrhosis whose ultrasound images aren’t clear enough. It aims to see which method works better and may help you get safer, more reliable follow-up.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.